Testis cancer: some problems still remain unsolved

Testis cancer: some problems still remain unsolved World J Urol (2017) 35:1159–1160 DOI 10.1007/s00345-017-2041-5 EDITORIAL 1 2 Peter Albers · Carsten Bokemeyer Received: 18 April 2017 / Accepted: 19 April 2017 / Published online: 16 May 2017 © Springer-Verlag Berlin Heidelberg 2017 In spite of an increasing incidence in most of the Northern of patients that cannot undergo complete resections [3]. industrialized countries in Europe germ cell cancer remains Salvage high-dose chemotherapy regimens are currently a rare disease. Diagnostic and management strategies have standard of care to treat recurrent disease. Exact classifica - been published numerously, but still there remain prob- tion of patients using the Lorch–Beyer classification system lems to be solved. Oldenburg and Dieckmann balanced the for recurrences and a large body of experience is necessary debate of pros and cons of a contralateral biopsy. Bottom to achieve optimal results with these potentially toxic regi- line is that a contralateral biopsy is the only way to early mens [4]. More and more data demand this salvage treat- detect cancer within the “testicular dysgenesis syndrome” ment to be regionalized in centers with high experience. which has been molecularly identified over the last years This exactly is true as well for the second component of by http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png World Journal of Urology Springer Journals

Testis cancer: some problems still remain unsolved

Loading next page...
 
/lp/springer_journal/testis-cancer-some-problems-still-remain-unsolved-1V7Copajj3
Publisher
Springer Berlin Heidelberg
Copyright
Copyright © 2017 by Springer-Verlag Berlin Heidelberg
Subject
Medicine & Public Health; Urology; Nephrology; Oncology
ISSN
0724-4983
eISSN
1433-8726
D.O.I.
10.1007/s00345-017-2041-5
Publisher site
See Article on Publisher Site

References

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 12 million articles from more than
10,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Unlimited reading

Read as many articles as you need. Full articles with original layout, charts and figures. Read online, from anywhere.

Stay up to date

Keep up with your field with Personalized Recommendations and Follow Journals to get automatic updates.

Organize your research

It’s easy to organize your research with our built-in tools.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

Monthly Plan

  • Read unlimited articles
  • Personalized recommendations
  • No expiration
  • Print 20 pages per month
  • 20% off on PDF purchases
  • Organize your research
  • Get updates on your journals and topic searches

$49/month

Start Free Trial

14-day Free Trial

Best Deal — 39% off

Annual Plan

  • All the features of the Professional Plan, but for 39% off!
  • Billed annually
  • No expiration
  • For the normal price of 10 articles elsewhere, you get one full year of unlimited access to articles.

$588

$360/year

billed annually
Start Free Trial

14-day Free Trial